| 2000-11 | Characterization of amiodarone metabolites and impurities using liquid chromatography/atmospheric pressure chemical ionization mass spectrometry | Myung, SW; Chang, YJ; Min, HK; Kim, DH; Kim, M; Kang, T; Yoo, EA; Sohn, YT; Yim, YH |
| - | Characterization of amiodarone metabolites and its impurities by HPLC/APCI-MS/MS | Myung Seung Woon; CHANG YOON-JUNG; Min Hye-Ki; Kim Myung Soo; 강태경; Eunah Yu; 임용현 |
| - | Identification of the amiodarone and its metabolites by HPLC and ESI - MS | Myung Seung Woon; Min Hye-Ki; Kim Myung Soo; 강태경; Eunah Yu |
| - | Identification of the amiodarone and its metabolites by HPLC and mass spectrometry | Myung Seung Woon; Min Hye-Ki; Kim Myung Soo; 조현우 |
| 2020-07 | Increased hepatic acylcarnitines after oral administration of amiodarone in rats | Kim, Gabin; Choi, Hyung-Kyoon; Lee, Hwanhui; Moon, Kyoung-Sik; Oh, Jung Hwa; Lee, Jaeick; Shin, Jae Gook; Kim, Dong Hyun |
| 2011-03 | Phospholipidosis Induced by PPAR gamma Signaling in Human Bronchial Epithelial (BEAS-2B) Cells Exposed to Amiodarone | Song, Mee; Kim, Youn-Jung; Ryu, Jae-Chun |
| - | Toxicogenomics Study on amiodarone-induced pulmonary toxic mechanism in lung epithelial (BEAS-2B) Cells | Song Mee; Kim Youn-Jung; 이하은; Ryu, Jae Chun |
